BioSpace News Archive

PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, announces that it has been named to the 37th Annual Inc. 5000 list, recognizing the fastest-growing private companies in America. PANTHERx® is being recognized on this prestigious national list as the 49th fastest growing company overall and the 5th fastest growing company in Health.

Health Canada is advising Canadians that, as a precautionary measure, Teva Canada is expanding its voluntary recall to include eight additional lots of valsartan products in Canada because they may contain an impurity, N-nitrosodimethylamine (NDMA).

OncoTracker, Inc. announced the appointment of James Kuo, MD, MBA, as its Chief Executive Officer. Dr. Kuo is a biotech executive with more than 20 years of experience in corporate development, finance and licensing.

Last week, GoodLife Fitness delivered more than $330,000 in new fitness equipment to Toronto Western Hospital and Toronto Rehab’s Rumsey Centre.

Merial, now part of Boehringer Ingelheim, and the maker of HEARTGARD® Plus (ivermectin/pyrantel), the leader in canine heartworm disease prevention, brings heartworm disease prevention and broad-spectrum treatment of intestinal parasites to felines, with new easy-to-use CENTRAGARD.

The latest results from the Global Anticoagulant Registry in the Field - Atrial Fibrillation (GARFIELD-AF) will be presented at the forthcoming ESC Congress 2018, organised by the European Society of Cardiology, to be held in Munich, Germany, from 25th to 29th August.

MedPartners Locum Tenens announced today that it is changing its corporate name to MPLT Healthcare.

Integrated Prescription Management (“IPM” or the “Company”) announced it has received a growth investment from Court Square Capital Partners (“Court Square”), a leading middle market private equity firm.

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts on Monday, August 27, 2018 at 9:00 a.m. EDT.

Johnson & Johnson will host a conference call for investors at 8:00 a.m. (Eastern Time) on Thursday, September 13th, to review its Pharmaceutical Business.